Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kymera Therapeutics, Inc.

46.18
-0.1700-0.37%
Post-market: 46.180.00000.00%17:31 EDT
Volume:501.45K
Turnover:23.29M
Market Cap:3.24B
PE:-14.84
High:47.30
Open:46.74
Low:46.00
Close:46.35
Loading ...

Truist Financial Remains a Buy on Kymera Therapeutics (KYMR)

TIPRANKS
·
26 Jun

Kymera Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $60 From $54

THOMSON REUTERS
·
26 Jun

Kymera Therapeutics price target lowered to $53 from $57 at Wells Fargo

TIPRANKS
·
26 Jun

Optimistic Outlook for Kymera Therapeutics Amid Strategic Partnerships and Strong KT-621 Prospects

TIPRANKS
·
26 Jun

U.S. RESEARCH ROUNDUP-Aerovironment, Cisco, Dell Technologies

Reuters
·
26 Jun

BUZZ-Kymera Therapeutics falls after launching $250 mln stock offering

Reuters
·
26 Jun

Kymera Therapeutics announces $250M common stock offering

TIPRANKS
·
26 Jun

Kymera Therapeutics Inc - Commences $250 Mln Public Offering

THOMSON REUTERS
·
26 Jun

Leerink Partners Remains a Buy on Kymera Therapeutics (KYMR)

TIPRANKS
·
26 Jun

Kymera weakness a buying opportunity, says Stifel

TIPRANKS
·
25 Jun

Kymera: Sanofi Ends KT-474 Work, Will Advance KT-485

Dow Jones
·
25 Jun

Kymera Therapeutics Unveils Presentation on Revolutionizing Immunology with Oral Medicines

Reuters
·
25 Jun

Gilead Sciences, Kymera Therapeutics Set Cancer-Drug Collaboration

Dow Jones
·
25 Jun

Gilead, Kymera enter license agreement for molecular glue degrader program

TIPRANKS
·
25 Jun

Kymera says Sanofi to advance KT-485 into clinical testing

TIPRANKS
·
25 Jun

BRIEF-Kymera Therapeutics Announces Sanofi Irak4 Collaboration Update

Reuters
·
25 Jun

Kymera Therapeutics Announces Sanofi Irak4 Collaboration Update

THOMSON REUTERS
·
25 Jun

Kymera Therapeutics Inc - Sanofi to Advance Kymera's KT-485 Into Clinical Testing

THOMSON REUTERS
·
25 Jun

Kymera Therapeutics Inc - Eligible for up to $975 Mln in Milestones

THOMSON REUTERS
·
25 Jun

BRIEF-Gilead Sciences And Kymera Therapeutics Enter Into Exclusive Option And License Agreement

Reuters
·
25 Jun